Polymedication in the elderly

Yesmine Jallouli; Othman Rym Ben; Syrine Trabelsi; Hmida Yosra Ben; Ramla Mizouri; Olfa Berriche; Henda Jamoussi; Faten Mahjoub

doi:10.1530/endoabs.99.EP828

EP828

Prev Next

Section Contents Cite

Endocrine Abstracts (2024) 99 EP828 | DOI: 10.1530/endoabs.99.EP828

ECE2024 Eposter Presentations Diabetes, Obesity, Metabolism and Nutrition (383 abstracts)

Polymedication in the elderly

Yesmine Jallouli ¹ , Rym Ben Othman ² , Syrine Trabelsi ³ , Yosra Ben Hmida ³ , Ramla Mizouri ³ , Olfa Berriche ³ , Henda Jamoussi ³ & Faten Mahjoub ³

Err

Author affiliations

¹Tunis, dapartment A, tunis; ²Tunisia, dapartment A, tunis, Tunisia; ³National Institue Of Nutrition and food technology, dapartment A, tunis

Introduction: Polymedication is a major problem affecting an increasing number of patients, particularly the elderly which can be deleterious in terms of quality of life, morbidity and mortality.

Objective: The aim of the present study was to determine the prevalence of polymedication in elderly diabetic patients.

Methods: This was a descriptive cross-sectional study conducted at the Institut National de Nutrition in 2023 in diabetic patients aged over 70. Polymedication was defined as taking more than five tablets per day.

Results: We enrolled 70 diabetic patients. The mean age of the population was 73±2.4 years, with females predominating (65.1%). Diabetes was poorly controlled in 73.77% of patients, with a mean glycated hemoglobin of 10.54%±2.16. Diabetes was complicated by retinopathy in 61% of cases. Comorbidities were dominated by hypertension and dyslipidemia in 84.1% and 85.7% of patients respectively. Polymedication concerned 64% of the study population. Statins were the most prescribed pharmaceutical class (78.2%), followed by antihypertensive drugs (69.7%), oral antidiabetics 51.2%)

Conclusion: Polymedication was common among elderly diabetic subjects. This may increase the risk of drug interactions and poor compliance.